En esta página
01PDSB precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
PDSB PDS Biotechnology Corporation - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 13, 2026
$0,75
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$0,20mínimo 52 semanas
$1,55máximo 52 semanas
Capitalización Bursátil (MRQ)
$42M
P/E
-1.0
BPA
$-0.74
tus insignias
Rango 52S
$0–$2
Calificación del Analista
BUY
Precio Objetivo
$5
P/E
-1.0
ROE
·
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
PDSB Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$0.75
Capitalización Bursátil (MRQ)
$42M
P/E
-1.0
BPA
$-0.74
Rango 52S
$0–$2
PDSB Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 18 de marzo de 2019 | 1-for-20 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$-0.742020-12-31 → 2025-12-31
Flujo de caja libre·2016-12-31 → 2024-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | PDSB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -1.0promedio 5A ≈-5.5 | ≈-5.5 | · | · | |
| P/C (MRQ) | -11.7promedio 5A ≈4.4 | ≈4.4 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 4.6promedio 5A ≈5.4 | ≈5.4 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | PDSB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 0.6promedio 5A ≈8.3 | ≈8.3 | 3.7 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
10.0%
Próximo informe
Nov 11, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 13, 2026 | $-0.18 | $-0.13 | -35.7% |
| 31 de marzo de 2026 | May 13, 2026 | $-0.13 | $-0.15 | 15.0% |
| 31 de diciembre de 2025 | $-0.15 | $-0.19 | 24.4% | |
| 30 de septiembre de 2025 | $-0.19 | $-0.22 | 12.7% | |
| 30 de junio de 2025 | $-0.21 | $-0.24 | 11.8% | |
| 31 de marzo de 2025 | $-0.21 | $-0.25 | 16.5% | |
| 31 de diciembre de 2024 | $-0.21 | $-0.28 | 25.6% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $19M | $23M | $28M | $29M | $11M | $8M | $6M | $830.7K | $34M | $25M | $18M | $8M | |
| SG&A Expense | $13M | $14M | $15M | $12M | $10M | $7M | $11M | $3M | $18M | $15M | $9M | $5M | |
| Operating Expenses | $32M | $36M | $43M | $42M | $21M | $15M | $21M | $4M | $52M | $40M | $26M | $13M | |
| Operating Income | $-32M | $-36M | $-43M | $-42M | $-21M | $-15M | $-21M | $-4M | $-52M | $-40M | $-26M | $-13M | |
| Interest Expense | · | · | $4M | $1M | $0 | $0 | $33.6K | $3.6K | $2M | $1M | $816.5K | $183.2K | |
| Interest Income | $1M | $3M | $3M | $935.2K | $4.3K | $55.0K | $353.5K | $0 | · | · | · | · | |
| Other Non-op | · | · | · | · | · | · | · | $-190.3K | · | · | · | · | |
| Pretax Income | $-36M | $-38M | $-44M | $-42M | $-21M | $-15M | $-7M | $-4M | $-53M | $-41M | $-29M | $-13M | |
| Income Tax | $-1M | $-869.2K | $-1M | $-1M | $-5M | $0 | $-381.5K | $0 | $-3M | $-2M | $-1M | $-590.7K | |
| Net Income | $-34M | $-38M | $-43M | $-41M | $-17M | $-15M | $-7M | $-4M | $-51M | $-39M | $-28M | $-12M | |
| EPS (Basic) | $-0.74 | $-1.03 | $-1.39 | $-1.43 | $-0.66 | $-0.89 | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.74 | $-1.03 | $-1.39 | $-1.43 | $-0.66 | $-0.89 | · | · | · | · | · | · | |
| Shares (Basic) | 46,384,280 | 36,452,707 | 30,952,060 | 28,599,221 | 25,597,125 | 16,745,044 | · | · | · | · | · | · | |
| Shares (Diluted) | 46,384,280 | 36,452,707 | 30,952,060 | 28,599,221 | 25,597,125 | 16,745,044 | · | · | · | · | · | · | |
| EBITDA | · | $-36M | $-43M | · | $-21M | $-15M | $-21M | $-43M | $-52M | $-40M | $-26M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $27M | $42M | $57M | $74M | $65M | $29M | $12M | $103.7K | $88M | $106M | $130M | $14M | |
| Prepaid Expense | $2M | $3M | $2M | $3M | $2M | $1M | $2M | $18.4K | $986.7K | $954.6K | $1M | $213.0K | |
| Current Assets | $28M | $45M | $59M | $76M | $67M | $30M | $14M | $122.1K | $89M | $107M | $131M | $15M | |
| PP&E (Net) | $120.2K | $142.0K | $134.1K | $0 | $86 | $5.4K | $21.1K | $29.5K | $3M | $3M | $3M | $1M | |
| PP&E (Gross) | $295.9K | $295.9K | $266.9K | $115.4K | $115.4K | $115.4K | $115.4K | $101.8K | $4M | $4M | $3M | $1M | |
| Accum. Depreciation | $175.7K | $153.9K | $132.8K | $115.4K | $115.3K | $110.0K | $94.4K | $72.3K | $305.3K | $122.4K | $91.4K | $38.3K | |
| Intangibles | · | · | · | · | · | $3M | $3M | $0 | · | · | · | · | |
| Other Non-current Assets | · | · | · | · | · | · | $0 | $12.8K | $142.9K | $142.9K | $55.2K | $55.2K | |
| Total Assets | $30M | $45M | $59M | $77M | $67M | $31M | $14M | $164.4K | $93M | $111M | $134M | $17M | |
| Accounts Payable | $4M | $2M | $7M | $1M | $1M | $1M | $1M | $1M | $4M | $3M | $3M | $2M | |
| Accrued Liabilities | $742.2K | $3M | $2M | $8M | $2M | $2M | $1M | $601.9K | $5M | $3M | $4M | $2M | |
| Current Liabilities | $9M | $17M | $14M | $10M | $4M | $3M | $3M | $2M | $13M | $7M | $9M | $4M | |
| Capital Leases | · | · | $0 | $0 | $231.4K | $490.4K | $0 | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | $0 | · | · | · | · | |
| Total Liabilities | $21M | $26M | $33M | $33M | $4M | $4M | $3M | $2M | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | $5M | · | |
| Common Stock | $18.1K | $12.5K | $10.9K | $10.0K | $9.4K | $7.3K | $1.7K | $1.1K | $10.4K | $9.8K | $9.7K | $770 | |
| Paid-in Capital | $226M | $201M | $171M | $146M | $124M | $71M | $41M | $20M | $214M | $190M | · | · | |
| Retained Earnings | $-217M | $-182M | $-145M | $-102M | $-61M | $-44M | $-29M | $-22M | $-152M | $-101M | $-62M | $-30M | |
| Stockholders' Equity | $9M | $19M | $26M | $44M | $63M | $27M | $12M | $-2M | $-609.5K | $89M | $122M | $-28M | |
| Liabilities + Equity | $30M | $45M | $59M | $77M | $67M | $31M | $14M | $164.4K | $93M | $111M | $134M | $17M | |
| Shares Outstanding | 54,878,233 | 37,987,380 | 33,094,521 | 30,170,317 | 28,448,612 | 22,261,619 | 5,281,237 | 3,417,187 | 30,869,205 | 28,918,516 | 28,810,845 | 1,688,475 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $15.6K | $98.4K | $69.1K | · | · | · | · | |
| Stock-based Comp | $4M | $7M | $8M | $5M | $4M | $432.3K | $3M | $866.8K | $6M | $5M | $3M | $1M | |
| Deferred Tax | · | · | · | · | · | $0 | $-381.5K | $0 | · | · | · | · | |
| Restructuring | · | · | · | · | · | · | $2M | $10M | $0 | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | $-14M | · | · | · | · | · | |
| Operating Cash Flow | $-28M | $-35M | $-34M | $-26M | $-12M | $-13M | $-18M | $-2M | $-41M | $-32M | $-22M | $-10M | |
| CapEx | $0 | $29.0K | $0 | · | · | · | · | $0 | $188.7K | $686.7K | $1M | $884.8K | |
| Investing Cash Flow | $0 | $-29.0K | $0 | · | · | $0 | $29M | $0 | $-188.7K | $-686.7K | $-1M | · | |
| Stock Issued | $10M | $0 | $16M | $10M | $49M | $30M | $750.0K | $1M | · | · | · | · | |
| Net Stock Activity | · | $23M | $16M | · | $49M | $30M | $750.0K | · | · | · | · | · | |
| Financing Cash Flow | $13M | $20M | $16M | $34M | $49M | $30M | $750.0K | $1M | $23M | $9M | $140M | · | |
| Net Change in Cash | · | · | · | · | · | · | · | $-53M | $-18M | $-24M | $116M | $6M | |
| Taxes Paid | $-1M | $-924.2K | · | · | · | · | $0 | $500 | · | · | · | · | |
| Free Cash Flow | · | $-35M | · | · | · | · | · | $-33M | $-41M | $-33M | $-23M | · | |
| Levered FCF | · | · | · | · | · | · | · | $-34M | $-43M | $-34M | $-24M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | -71.8% | -63.0% | · | -34.5% | -65.4% | -95.5% | -63.4% | -50.0% | -31.7% | -37.2% | · | |
| ROE | · | -183.4% | -169.7% | · | -25.8% | -51.1% | -51.3% | -284.2% | -67.1% | -36.7% | -59.3% | · | |
| ROIC | · | -186.8% | -159.5% | · | -26.8% | -54.9% | -189.1% | -135.2% | -79.3% | -42.2% | -20.8% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.6 | 4.3 | · | 17.8 | 9.3 | 5.2 | 5.6 | 6.9 | 16.1 | 15.3 | · | |
| Quick Ratio | · | 2.4 | 4.1 | · | 17.4 | 8.8 | 4.4 | 5.4 | 6.8 | 15.9 | 15.2 | · | |
| Interest Coverage | · | · | -10.2 | · | · | · | -626.8 | -30.2 | -23.8 | -32.8 | -32.5 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $0.50 | $0.79 | · | $2.22 | $1.22 | $2.21 | $0.95 | $2.02 | $3.09 | $4.25 | · | |
| Cash Flow / Share | · | $-0.96 | $-1.09 | · | $-0.49 | · | · | · | · | · | · | · | |
| Cash / Share | · | $1.10 | $1.71 | · | $2.29 | $1.30 | $2.30 | $1.10 | $2.85 | $3.68 | $4.52 | · | |
| EPS (TTM) | $-0.74 | $-1.03 | $-1.39 | $-1.43 | $-0.66 | $-0.89 | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-34M | $-38M | $-43M | $-41M | $-17M | $-15M | $-7M | $-4M | $-51M | $-39M | $-28M | · | |
| Market Cap | · | $62M | $164M | · | $230M | $48M | $14M | $202M | $5.78B | $7.23B | $7.20B | · | |
| P/E | -1.0 | -1.6 | -3.6 | -9.2 | -12.3 | -2.4 | · | · | · | · | · | · | |
| P/B | · | 3.3 | 6.3 | · | 3.6 | 1.8 | 1.2 | 6.8 | 92.7 | 81.0 | 58.8 | · | |
| P / Tangible Book | 4.6 | 3.3 | 6.3 | 9.1 | 3.6 | 2.0 | · | · | · | · | · | · | |
| P / Cash Flow | · | -1.8 | -4.9 | · | -18.5 | -3.6 | -0.8 | -6.1 | -142.1 | -224.6 | -331.1 | · | |
| P / FCF | · | -1.8 | · | · | · | · | · | -6.1 | -141.5 | -219.9 | -312.4 | · | |
| Earnings Yield | -96.1% | -63.2% | -28.0% | -10.8% | -8.2% | -41.6% | · | · | · | · | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $3M | $4M | $5M | $4M | $6M | $5M | $7M | $5M | $7M | $7M | $6M | $8M | $6M | $16M | $4M | |
| SG&A Expense | $3M | $3M | $2M | $4M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $4M | $5M | $4M | $3M | $3M | |
| Operating Expenses | $6M | $7M | $7M | $8M | $8M | $9M | $7M | $10M | $9M | $10M | $10M | $11M | $13M | $9M | $19M | $7M | |
| Operating Income | $-6M | $-7M | $-7M | $-8M | $-8M | $-9M | $-7M | $-10M | $-9M | $-10M | $-10M | $-11M | $-13M | $-9M | $-19M | $-7M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | $1M | $995.4K | $966.8K | $919.2K | $397.3K | |
| Interest Income | $125.4K | $186.8K | $224.7K | $281.1K | $333.6K | $377.8K | $503.9K | $666.8K | $675.2K | $668.9K | $683.5K | $739.4K | $750.7K | $729.3K | $602.9K | $252.1K | |
| Pretax Income | $-10M | $-7M | $-8M | $-9M | $-9M | $-10M | $-8M | $-11M | $-9M | $-11M | $-11M | $-11M | $-13M | · | $-19M | $-7M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $-1M | $0 | $0 | $-869.2K | $0 | $2 | $0 | $-1M | · | $0 | $0 | |
| Net Income | $-10M | $-7M | $-8M | $-9M | $-9M | $-8M | $-8M | $-11M | $-8M | $-11M | $-11M | $-11M | $-12M | $-10M | $-19M | $-7M | |
| EPS (Basic) | $-0.18 | $-0.13 | $-0.13 | $-0.19 | $-0.21 | $-0.21 | $-0.21 | $-0.29 | $-0.23 | $-0.30 | $-0.35 | $-0.35 | $-0.37 | $-0.32 | $-0.65 | $-0.26 | |
| EPS (Diluted) | $-0.18 | $-0.13 | $-0.13 | $-0.19 | $-0.21 | $-0.21 | $-0.21 | $-0.29 | $-0.23 | $-0.30 | $-0.35 | $-0.35 | $-0.37 | $-0.32 | $-0.65 | $-0.26 | |
| Shares (Basic) | 55,659,669 | 55,496,279 | · | 46,869,531 | 45,902,502 | 40,521,001 | · | 36,806,592 | 36,693,561 | 34,815,870 | · | 30,910,520 | 30,802,498 | 30,428,053 | · | 28,458,688 | |
| Shares (Diluted) | 55,659,669 | 55,496,279 | · | 46,869,531 | 45,902,502 | 40,521,001 | · | 36,806,592 | 36,693,561 | 34,815,870 | · | 30,910,520 | 30,802,498 | 30,428,053 | · | 28,458,688 | |
| EBITDA | $-6M | $-7M | · | $-8M | $-8M | $-9M | · | $-10M | $-9M | $-10M | · | $-11M | $-13M | $-9M | · | $-7M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6M | $22M | $27M | $26M | $32M | $40M | $42M | $50M | $58M | $67M | $57M | $54M | $61M | $65M | $74M | $72M | |
| Prepaid Expense | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | |
| Current Assets | $7M | $23M | $28M | $28M | $34M | $42M | $45M | $52M | $60M | $69M | $59M | $57M | $63M | $68M | $76M | $74M | |
| PP&E (Net) | $176.6K | $114.7K | $120.2K | $125.6K | $131.1K | $136.6K | $142.0K | $147.5K | $152.9K | $129.4K | $134.1K | $138.9K | $143.6K | $148.3K | $0 | $0 | |
| PP&E (Gross) | · | · | $295.9K | · | · | · | $295.9K | · | · | · | $266.9K | · | · | · | $115.4K | · | |
| Accum. Depreciation | · | · | $175.7K | · | · | · | $153.9K | · | · | · | $132.8K | · | · | · | $115.4K | · | |
| Total Assets | $9M | $25M | $30M | $35M | $40M | $47M | $45M | $52M | $60M | $69M | $59M | $57M | $64M | $68M | $77M | $75M | |
| Accounts Payable | $6M | $4M | $4M | $5M | $4M | $3M | $2M | $1M | $3M | $6M | $7M | $5M | $4M | $2M | $1M | $2M | |
| Accrued Liabilities | $2M | $1M | $742.2K | $2M | $1M | $3M | $3M | $4M | $2M | $2M | $2M | $4M | $3M | $2M | $8M | $2M | |
| Current Liabilities | $12M | $10M | $9M | $13M | $12M | $18M | $17M | $18M | $16M | $15M | $14M | $9M | $8M | $4M | $10M | $5M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Total Liabilities | $12M | $21M | $21M | $25M | $25M | $25M | $26M | $30M | $30M | $32M | $33M | $33M | $31M | $27M | $33M | $28M | |
| Common Stock | $18.5K | $18.4K | $18.1K | $15.7K | $15.4K | $15.0K | $12.5K | $12.2K | $12.1K | $12.1K | $10.9K | $10.2K | $10.2K | $10.1K | $10.0K | $9.4K | |
| Paid-in Capital | $230M | $228M | $226M | $218M | $216M | $213M | $201M | $196M | $194M | $192M | $171M | $158M | $155M | $152M | $146M | $129M | |
| Retained Earnings | $-234M | $-224M | $-217M | $-209M | $-200M | $-191M | $-182M | $-174M | $-163M | $-155M | $-145M | $-134M | $-123M | $-111M | $-102M | $-82M | |
| Stockholders' Equity | $-4M | $4M | $9M | $9M | $16M | $22M | $19M | $22M | $31M | $37M | $26M | $24M | $32M | $41M | $44M | $47M | |
| Liabilities + Equity | $9M | $25M | $30M | $35M | $40M | $47M | $45M | $52M | $60M | $69M | $59M | $57M | $64M | $68M | $77M | $75M | |
| Shares Outstanding | 55,921,806 | 55,815,653 | 54,878,233 | 47,705,442 | 46,633,362 | 45,445,851 | 37,987,380 | 36,819,810 | 36,779,275 | 36,679,275 | 33,094,521 | 31,007,763 | 30,868,188 | 30,723,610 | 30,170,317 | 28,458,688 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $1M | $1M | $448.0K | $1M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $1M | |
| Operating Cash Flow | $-3M | $-4M | $-4M | $-6M | $-9M | $-9M | $-8M | $-8M | $-9M | $-10M | $-8M | $-7M | $-5M | $-13M | $-8M | $-6M | |
| CapEx | · | · | $0 | $0 | · | · | $0 | $1 | · | · | $0 | $0 | · | · | · | · | |
| Investing Cash Flow | · | · | $0 | $0 | · | · | $0 | $-1 | · | · | $0 | $0 | · | · | · | · | |
| Stock Issued | $0 | $0 | $3M | $0 | $0 | $7M | $0 | $-19M | $0 | $0 | $11M | $800.0K | $200.0K | $5M | $10M | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $7M | · | · | $0 | $19M | · | $800.0K | $200.0K | $5M | · | · | |
| Financing Cash Flow | $-13M | $-679.8K | $4M | $241.2K | $995.9K | $7M | $172.8K | $17.2K | $-13.8K | $20M | $11M | $802.3K | $240.0K | $5M | $10M | $25M |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -39.6% | -20.5% | · | -20.7% | -18.7% | -14.6% | · | -19.6% | -13.4% | -15.4% | · | -16.4% | -19.3% | -14.9% | · | -10.1% | |
| ROE | -157.5% | -56.0% | · | -57.3% | -40.2% | -28.5% | · | -46.2% | -26.3% | -27.1% | · | -30.3% | -27.5% | -19.9% | · | -12.9% | |
| ROIC | 181.5% | -167.5% | · | -86.1% | -47.8% | -35.8% | · | -46.3% | -25.4% | · | · | -43.0% | -34.9% | · | · | -15.5% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.6 | 2.3 | · | 2.1 | 2.9 | 2.3 | · | 2.8 | 3.8 | 4.6 | · | 6.2 | 8.0 | 16.5 | · | 15.4 | |
| Quick Ratio | 0.5 | 2.1 | · | 2.0 | 2.8 | 2.2 | · | 2.7 | 3.7 | 4.4 | · | 5.9 | 7.7 | 15.8 | · | 14.8 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -8.6 | · | -9.8 | -12.8 | -9.7 | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.06 | $0.07 | · | $0.20 | $0.34 | $0.49 | · | $0.60 | $0.84 | $1.01 | · | $0.79 | $1.05 | $1.33 | · | $1.65 | |
| Cash Flow / Share | · | $-0.08 | · | · | · | $-0.22 | · | · | · | $-0.29 | · | · | · | $-0.43 | · | · | |
| Cash / Share | $0.10 | $0.39 | · | $0.55 | $0.68 | $0.88 | · | $1.35 | $1.57 | $1.82 | · | $1.75 | $1.96 | $2.12 | · | $2.52 | |
| EPS (TTM) | $-0.63 | $-0.66 | · | $-0.82 | $-0.92 | $-0.94 | · | $-1.17 | $-1.23 | $-1.37 | · | $-1.69 | $-1.60 | $-1.43 | · | $-1.03 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-34M | $-33M | · | $-35M | $-37M | $-35M | · | $-41M | $-41M | $-44M | · | $-51M | $-48M | $-42M | · | $-28M | |
| Market Cap | $49M | $34M | · | $48M | $62M | $54M | · | $141M | $108M | $145M | · | $157M | $155M | $189M | · | $85M | |
| P/E | -1.4 | -0.9 | · | -1.2 | -1.4 | -1.3 | · | -3.3 | -2.4 | -2.9 | · | -3.0 | -3.1 | -4.3 | · | -2.9 | |
| P/B | -13.8 | 8.7 | · | 5.1 | 3.9 | 2.4 | · | 6.4 | 3.5 | 3.9 | · | 6.4 | 4.8 | 4.6 | · | 1.8 | |
| P / Tangible Book | · | 8.7 | · | 5.1 | 3.9 | 2.4 | · | 6.4 | 3.5 | 3.9 | · | 6.4 | 4.8 | 4.6 | · | 1.8 | |
| P / Cash Flow | · | -7.7 | · | · | · | -6.0 | · | · | · | -14.6 | · | · | · | -14.3 | · | · | |
| Earnings Yield | -71.5% | -109.1% | · | -81.2% | -69.2% | -79.0% | · | -30.6% | -42.0% | -34.6% | · | -33.5% | -31.8% | -23.2% | · | -34.7% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Beneficio neto | $-34M | $-38M | $-43M | $-41M | $-17M |
| EPS Diluido | $-0.74 | $-1.03 | $-1.39 | $-1.43 | $-0.66 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | · | 2.6 | 4.3 | · | 17.8 |
| Ratio Rápido | · | 2.4 | 4.1 | · | 17.4 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | · | $-35M | · | · | · |
Propietarios institucionales (13F) 55 declarantes · $8.6M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
55
Valor en tenencia
$8.6M
Nuevas posiciones
14
Posiciones cerradas
4
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 14 (+5 vs trimestre anterior) | 4 (-5 vs trimestre anterior) | 14 (+3 vs trimestre anterior) | 7 (-2 vs trimestre anterior) | +2.7M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1 502 228 | 1 950 946 | 17,40% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 497 097 | 1 699 315 | 17,34% | Acciones |
| Quantinno Capital Management LP | $565 822 | 642 177 | 6,55% | Acciones |
| Focus Partners Wealth | $565 822 | 642 177 | 6,55% | Acciones |
| BlackRock, Inc. | $535 391 | 607 639 | 6,20% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $517 410 | 587 139 | 5,99% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $314 644 | 357 144 | 3,64% | Acciones |
| Militia Capital Management LLC | $292 349 | 331 800 | 3,39% | Acciones |
| CITADEL ADVISORS LLC | $285 301 | 323 801 | 3,30% | Acciones |
| Caption Management, LLC | $281 159 | 319 100 | 3,26% | Opción de compra |
| MORGAN STANLEY | $276 597 | 313 922 | 3,20% | Acciones |
| BLAIR WILLIAM & CO/IL | $264 330 | 300 000 | 3,06% | Acciones |
| JANE STREET GROUP, LLC | $246 412 | 279 664 | 2,85% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $222 213 | 252 200 | 2,57% | Acciones |
| INSPIRION WEALTH ADVISORS, LLC | $165 182 | 188 995 | 1,91% | Acciones |
| MARSHALL WACE, LLP | $129 510 | 147 171 | 1,50% | Acciones |
| STATE STREET CORP | $117 480 | 133 333 | 1,36% | Acciones |
| NORTHERN TRUST CORP | $111 461 | 126 502 | 1,29% | Acciones |
| WELLS FARGO & COMPANY/MN | $96 040 | 109 000 | 1,11% | Acciones |
| COMMONWEALTH EQUITY SERVICES, LLC | $81 940 | 92 997 | 0,95% | Acciones |
| Iron Gate Global Advisors LLC | $62 035 | 70 406 | 0,72% | Acciones |
| Bank of New York Mellon Corp | $60 348 | 68 491 | 0,70% | Acciones |
| Watts Gwilliam & Co., LLC | $55 550 | 55 000 | 0,64% | Acciones |
| Tempus Wealth Planning, LLC | $54 452 | 61 800 | 0,63% | Acciones |
| TWO SIGMA SECURITIES, LLC | $36 470 | 41 391 | 0,42% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $32 009 | 36 328 | 0,37% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $29 798 | 33 819 | 0,35% | Acciones |
| XTX Topco Ltd | $29 163 | 33 098 | 0,34% | Acciones |
| OSAIC HOLDINGS, INC. | $26 433 | 30 000 | 0,31% | Acciones |
| ACT CAPITAL MANAGEMENT, LLC | $26 433 | 30 000 | 0,31% | Acciones |
| Rockefeller Capital Management L.P. | $24 375 | 27 664 | 0,28% | Acciones |
| CITADEL ADVISORS LLC | $21 587 | 24 500 | 0,25% | Opción de compra |
| Federation des caisses Desjardins du Quebec | $17 444 | 19 800 | 0,20% | Acciones |
| Vanguard Global Advisers, LLC | $11 053 | 12 546 | 0,13% | Acciones |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | $10 573 | 12 000 | 0,12% | Acciones |
| PNC Financial Services Group, Inc. | $10 484 | 11 900 | 0,12% | Acciones |
| UBS Group AG | $9 798 | 11 121 | 0,11% | Acciones |
| GOLDMAN SACHS GROUP INC | $8 853 | 10 048 | 0,10% | Acciones |
| GRANDFIELD & DODD, LLC | $8 811 | 10 000 | 0,10% | Acciones |
| DAVENPORT & Co LLC | $8 811 | 10 000 | 0,10% | Acciones |
| Kathleen S. Wright Associates Inc. | $7 070 | 7 000 | 0,08% | Acciones |
| Tower Research Capital LLC (TRC) | $3 473 | 3 942 | 0,04% | Acciones |
| GROUP ONE TRADING LLC | $3 143 | 3 567 | 0,04% | Acciones |
| CREATIVE FINANCIAL DESIGNS INC /ADV | $2 643 | 3 000 | 0,03% | Acciones |
| JONES FINANCIAL COMPANIES LLLP | $1 776 | 2 000 | 0,02% | Acciones |
| Rialto Wealth Management, LLC | $671 | 761 | 0,01% | Acciones |
| Truvestments Capital LLC | $577 | 655 | 0,01% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $571 | 648 | 0,01% | Acciones |
| BARCLAYS PLC | $513 | 582 | 0,01% | Acciones |
| SBI Securities Co., Ltd. | $100 | 113 | 0,00% | Acciones |
Activistas y propietarios del %+ 5 5 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Nant Capital, LLC, Patrick Soon-Shiong | 21 de septiembre de 2026 | 19,90% | Presentación inicial | Campaña de la junta directiva | SEC |
| NetScientific Plc, Melvin Lawson ×3 presentaciones | 21 de junio de 2021 | · | Presentación inicial | Inversión pasiva | SEC |
| Sofinnova Venture Partners IX, L.P. (“SVP IX”), Sofinnova Management IX, L.L.C. (“SM IX”), Dr. Michael F. Powell (“Powell”), Dr. James I. Healy (“Healy”), Dr. Anand Mehra (“Mehra”) ×3 presentaciones | 28 de marzo de 2019 | · | Presentación inicial | Inversión pasiva | SEC |
| New Leaf Ventures III, L.P., New Leaf Biopharma Opportunities I, L.P., New Leaf Venture Associates III, L.P., New Leaf BPO Associates I, L.P., New Leaf Venture Management III, L.L.C., Vijay Lathi, Ronald Hunt, Liam Ratcliffe ×2 presentaciones | 25 de marzo de 2019 | · | Presentación inicial | Campaña de la junta directiva | SEC |
| Venrock Healthcare Capital Partners, L.P., Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings, LLC, VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Hove, Anders, Koh, Bong | 16 de octubre de 2015 | · | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 37 insiders · 20 directivos · 19 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Frank Bedu-Addo | President/CEO | 12 de enero de 2026 A | 690 866 | 0 | 0 | $0 |
| Brian A Leuthner | President and CEO | 15 de marzo de 2019 M | 239 268 | 0 | 0 | $0 |
| Lars Boesgaard | Chief Financial Officer | 12 de enero de 2026 A | · | 0 | 0 | $0 |
| Matthew C Hill | Chief Financial Officer | 5 de enero de 2023 A | 4 075 | 0 | 0 | $0 |
| Seth Van Voorhees | Chief Financial Officer | 15 de junio de 2021 P | 17 647 | 0 | 0 | $0 |
| Michael N. King | Interim CFO | 8 de diciembre de 2020 A | · | 0 | 0 | $0 |
| Andrew Saik | Chief Financial Officer | 14 de febrero de 2020 A | 42 549 | 0 | 0 | $0 |
| Andrew J. Einhorn | Chief Financial Officer | 1 de marzo de 2017 X | 43 223 | 0 | 0 | $0 |
| Stephan Toutain | Chief Operating Officer | 12 de enero de 2026 A | · | 0 | 0 | $0 |
| Daniel Brennan | Chief Operating Officer | 1 de marzo de 2018 A | · | 0 | 0 | $0 |
| Kirk V. Shepard | Chief Medical Officer | 12 de enero de 2026 A | · | 0 | 0 | $0 |
| Spencer D. Brown | Senior VP, General Counsel | 12 de enero de 2026 A | · | 0 | 0 | $0 |
| Gregory Conn | Chief Scientific Officer | 12 de enero de 2026 A | · | 0 | 0 | $0 |
| Lauren Wood | Chief Medical Officer | 5 de enero de 2023 A | · | 0 | 0 | $0 |
| Bradford W Middlekauff | Senior VP, GC and Secretary | 15 de marzo de 2019 M | 59 766 | 0 | 0 | $0 |
| Alyssa Wyant | SVP Regulatory Affairs | 14 de agosto de 2018 A | · | 0 | 0 | $0 |
| Herbert J Faleck | Chief Medical Officer | 14 de agosto de 2018 A | 500 | 0 | 0 | $0 |
| Albert N Marchio II | Chief Accounting & Adm Officer | 14 de agosto de 2018 A | 0 | 0 | 0 | $0 |
| Alpaslan Yaman | V.P., Technical Ops. & Mfg. | 13 de marzo de 2017 A | · | 0 | 0 | $0 |
| Renu Vaish | V.P., Global Reg. Affairs | 16 de junio de 2016 M | 5 350 | 0 | 0 | $0 |
| Ilian Iliev | Consejero | 12 de enero de 2026 A | · | 0 | 0 | $0 |
| Kamil Ali-Jackson | Consejero | 12 de enero de 2026 A | 11 764 | 0 | 0 | $0 |
| Gregory Gene Freitag | Consejero | 12 de enero de 2026 A | 61 213 | 0 | 0 | $0 |
| Steve C Glover | Consejero | 12 de enero de 2026 A | 78 851 | 0 | 0 | $0 |
| Otis W Brawley | Consejero | 12 de enero de 2026 A | · | 0 | 0 | $0 |
| Richard Sykes | Consejero | 24 de junio de 2024 A | 445 108 | 0 | 0 | $0 |
| James J Loughlin | Consejero | 28 de junio de 2019 A | 26 625 | 0 | 0 | $0 |
| Loch R. Macdonald | Consejero | 15 de marzo de 2019 M | 580 602 | 0 | 0 | $0 |
| Liam Ratcliffe | Consejero | 15 de marzo de 2019 M | 10 000 | 0 | 0 | $0 |
| Robert J. Spiegel | Consejero | 15 de marzo de 2019 M | 48 661 | 0 | 0 | $0 |
| Rosemary A Crane | Consejero | 15 de marzo de 2019 M | 10 000 | 0 | 0 | $0 |
| Sol J Barer | Consejero | 15 de marzo de 2019 M | 678 075 | 0 | 0 | $0 |
| Isaac Blech | Consejero | 15 de marzo de 2019 M | 10 000 | 0 | 0 | $0 |
| Kurt G Conti | Consejero | 23 de marzo de 2018 J | 0 | 0 | 0 | $0 |
| Dr. James I. Healy | Consejero | 20 de junio de 2017 A | 2 852 711 | 0 | 0 | $0 |
| Anders D Hove | Consejero | 6 de octubre de 2015 C | 2 068 582 | 0 | 0 | $0 |
| Delyle W Bloomquist | · | 16 de junio de 2021 M | 193 888 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 3 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
PDSB Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 9 analistas
COMPRA
Objetivo mediano
$4.75
+534,6%
2 22,2%
Compra fuerte
6 66,7%
Compra
1 11,1%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
2 analistas · 2026-09-28Objetivo medio $4.75 +534,6%
← Por Debajo de Todos los Objetivos
Precio Actual $0.75
Mín$4.50
Media$4.75
Máx$5.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 13, 2026